| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/08/2002 | US20020107386 Methods and compositions relating to bone-derived growth factor-like polypeptides |
| 08/08/2002 | US20020107385 Human breast tumor-specific proteins |
| 08/08/2002 | US20020107372 Nucleotide sequences coding membrane protein for use in the treatment of inflammation,lung defects and viral diseases |
| 08/08/2002 | US20020107370 Protein for use in the treatment of lzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, retinopathy, brain, blood, myocardium, stroke, reperfusion injury and liver disorders |
| 08/08/2002 | US20020107368 Helicobacter proteins, gene sequences and uses thereof |
| 08/08/2002 | US20020107360 Hepatitis E virus antigens and uses therefor |
| 08/08/2002 | US20020107225 Use of nucleoside analogues (cytosine or 5-fluorocytosine containing compound) useful for acute or chronic myelogenous leukemia |
| 08/08/2002 | US20020107224 Used as anti-tumor agents and/or anti-HIV agents having immunostimulate activities; inversion of OR2 to OR1 in glucopyranose derivtives (R1= H or acetyl, R2= a leaving group such as tosylate, trifluoromesylate or methanesulfonate |
| 08/08/2002 | US20020107210 Compositions and methods for the treatment of autoimmune diabetes |
| 08/08/2002 | US20020107199 Administering a Clostridium neurotoxin component using a needleless syringe to treat involunatary muscle contraction |
| 08/08/2002 | US20020107194 Able to bind to a Notch protein forming Delta-Notch complex |
| 08/08/2002 | US20020107192 Isolated 23686 proteins, fusion proteins, antigenic peptides and anti-23686 antibodies and diagnostic methods utilizing said |
| 08/08/2002 | US20020107187 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof |
| 08/08/2002 | US20020107186 Isolated NOVX polynucleotides and polypeptides encoded by them |
| 08/08/2002 | US20020107180 Cell surface glycoproteins |
| 08/08/2002 | US20020106798 Plasmid for use in vaccination of animals aganist fungal, bacterial and viral infections |
| 08/08/2002 | US20020106780 Extracellular matrix polynucleotides, polypeptides, and antibodies |
| 08/08/2002 | US20020106776 pth |
| 08/08/2002 | US20020106773 Protein-protein interactions in neurodegenerative diseases |
| 08/08/2002 | US20020106746 Nucleotide sequences coding preferential protein for use in the treatment of septic shock, liver and immunological, tumors and connective tissue defects |
| 08/08/2002 | US20020106732 Smad6 and uses thereof |
| 08/08/2002 | US20020106731 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of apoptosis and inflammation defects |
| 08/08/2002 | US20020106728 NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 08/08/2002 | US20020106726 Peptide for use in the treatment of inflammation defects |
| 08/08/2002 | US20020106655 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention of immunological, nervous system and tumor disorders |
| 08/08/2002 | US20020106641 Nucleotide sequences coding viral protein for use in vaccinations and veterinary medicine |
| 08/08/2002 | US20020106640 Peptide for use in the treatment and prevention of viral infection |
| 08/08/2002 | US20020106639 Postweaning multisystemic wasting syndrome virus from pigs |
| 08/08/2002 | US20020106397 Inoculating female birds withimmunogen, harvesting eggs which contain antibodies to immunogen, drying egg contents and adding to feed or water for host animals for inhibiting ability of immunogen to adhere to rumen or intestinal tracts |
| 08/08/2002 | US20020106381 Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus |
| 08/08/2002 | US20020106380 rSOWgp58 protein and its use as an antigen |
| 08/08/2002 | US20020106376 Vaccines |
| 08/08/2002 | US20020106374 Compositions and methods for inhibition of HIV-1 infection |
| 08/08/2002 | US20020106371 For therapy of sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura |
| 08/08/2002 | US20020106370 Improvements in or relating to peptide delivery |
| 08/08/2002 | US20020106369 Method of inhibiting stenosis and restenosis |
| 08/08/2002 | US20020106324 Treating cancer whereof the cells exhibit overexpression of a product of a gene of the myc-related family |
| 08/08/2002 | CA2444661A1 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 08/08/2002 | CA2437555A1 Stabilised polymeric aerosols for pulmonary gene delivery |
| 08/08/2002 | CA2437072A1 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses |
| 08/08/2002 | CA2436530A1 Environmentally regulated genes of streptococcus suis |
| 08/08/2002 | CA2436411A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 08/08/2002 | CA2436403A1 Anti-rubeola antibody for treating crohn's disease |
| 08/08/2002 | CA2436281A1 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | CA2436266A1 Pyk2 phosphorylation by her3 induces tumor invasion |
| 08/08/2002 | CA2436092A1 Modified antibodies and methods of use |
| 08/08/2002 | CA2434953A1 Protein modification and maintenance molecules |
| 08/08/2002 | CA2434822A1 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof |
| 08/08/2002 | CA2432867A1 A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/08/2002 | CA2432731A1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 08/08/2002 | CA2426587A1 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans |
| 08/07/2002 | EP1229045A1 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 08/07/2002 | EP1229042A1 Cyclic peptides and aids vaccines |
| 08/07/2002 | EP1228768A1 Medicament for the protection against thrombotic diseases |
| 08/07/2002 | EP1228766A1 PYK2 phosphorylation by HER3 induces tumor invasion |
| 08/07/2002 | EP1228373A2 Diagnosis and therapy of cancer using sgp28-related molecules |
| 08/07/2002 | EP1228231A1 Mammalian-type glycosylation in plants |
| 08/07/2002 | EP1228224A1 Recombinant attenuated listerias for immunotherapy |
| 08/07/2002 | EP1228217A2 Conserved neisserial antigens |
| 08/07/2002 | EP1228212A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 08/07/2002 | EP1228208A2 36p6d5: secreted tumor antigen |
| 08/07/2002 | EP1228203A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 08/07/2002 | EP1228193A2 Feline calicivirus genes and vaccines, in particular recombined vaccines |
| 08/07/2002 | EP1228095A1 Modified gp100 and uses thereof |
| 08/07/2002 | EP1228088A2 Novel traf family proteins |
| 08/07/2002 | EP1228086A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 08/07/2002 | EP1228085A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 08/07/2002 | EP1228044A2 Pyrrolo imidazole derivatives and their use as medicaments |
| 08/07/2002 | EP1227842A1 Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5 |
| 08/07/2002 | EP1227841A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 08/07/2002 | EP1227840A1 Adjuvanted genetic vaccines |
| 08/07/2002 | EP1227839A2 Live bacterial vaccines against escherichia coli o157:h7 |
| 08/07/2002 | EP1227838A2 Melanoma vaccine and methods of making and using same |
| 08/07/2002 | EP1227837A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 08/07/2002 | EP1227834A2 Use of caspase-14 and caspase-14 modulators to diagnose and/or treat skin, eye and brain disorders |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1227828A1 Viruses for the treatment of cellular proliferative disorders |
| 08/07/2002 | EP1227808A2 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 08/07/2002 | EP0809517B1 Anti-transforming growth factor-beta gene therapy |
| 08/07/2002 | EP0762895B1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 08/07/2002 | CN1362992A Combination neisserial compositions |
| 08/07/2002 | CN1362970A Monoclonal antibody against estrogen-stimulated leucine aminopeptidase |
| 08/07/2002 | CN1362885A AIDS virus vaccine with use of sendai virus vector |
| 08/07/2002 | CN1362880A Immunomodulating polymers |
| 08/07/2002 | CN1362418A Anticholera vibrio, its toxic chicken yolk antibody and the prepn and application |
| 08/07/2002 | CN1362263A Recombinant protein vaccine for preventing and treating human prostata cancer |
| 08/07/2002 | CN1088599C Therapeutic compositions comprising antigen or an in vivo generator comprising amino-acid serial compounds |
| 08/07/2002 | CN1088598C Culture process of high-yield weak-toxicity distemper cell strain |
| 08/07/2002 | CA2369202A1 Live vaccines for allergy treatment |
| 08/06/2002 | US6429306 Library screening; restriction mapping, cloning, genetic engineering, gene expression; probes for diagnostic kits |
| 08/06/2002 | US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
| 08/06/2002 | US6429295 Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 08/06/2002 | US6429208 Administering 2',5'-dideoxyadenosine to inhibit protein kinase a/cyclic adenosine monophosphate pathway; reverses effects of hiv infection; allows for lymphocyte proliferation |
| 08/06/2002 | US6429201 Method for immunization against hepatitis B |
| 08/06/2002 | US6429199 Immunostimulatory nucleic acid molecules for activating dendritic cells |
| 08/06/2002 | US6428807 Matrix of saponin preparation, a sterol, a phospholipid and a metal chelating moeity that can bind a protein or polypeptide |
| 08/06/2002 | US6428793 Lipoglycan compositions and methods of treating parasitic infections |
| 08/06/2002 | US6428789 Administering antigens obtained from dermatophytes to animals; innoculation; immunology |
| 08/06/2002 | US6428788 Preferential drug delivery to tumors having interleukin receptors; side effect reduction |
| 08/06/2002 | US6428787 TNF inhibitors for the treatment of retinal disorders |